MEC Basic – MyMedflix Member Portal

Skip to content

Live Events

Live Events

Live Events

Live Events

MEC Basic

Events

Speciality

Type of Media

Author / Speaker

Title

Search Entries:

«
1
2
3
4
…
66
»

Classification and Management of Short and Long Term Complications in Esophageal Cancer Surgery

Classification and Management of Short and Long Term Complications in Esophageal Cancer Surgery

Steven Hochwald, MD

Robotic Approaches to Surgical Resection in Esophageal Cancer

Robotic Approaches to Surgical Resection in Esophageal Cancer

Steven Hochwald, MD

Hereditary GI Cancer Genetics

Hereditary GI Cancer Genetics

Fay Kastrinos, MD

Which Patients with Esophageal Cancer Should Undergo Chemoradiotherapy without Surgery

Which Patients with Esophageal Cancer Should Undergo Chemoradiotherapy without Surgery

Manish A. Shah, MD

Management of Precancerous Lesions and Early Esophageal Carcinoma with Endoscopic Advancements

Management of Precancerous Lesions and Early Esophageal Carcinoma with Endoscopic Advancements

Andrew Wang, MD

Genetic Abnormalities and Active Targets in Esophageal Cancer

Genetic Abnormalities and Active Targets in Esophageal Cancer

William Grady, MD

Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

Current Epidemiology and Incidence of Esophageal Cancer: East vs West; Implications on Clinical Trials

Brian Henick, MD

Response Predictors for Breast Cancer Immunotherapy

Response Predictors for Breast Cancer Immunotherapy

Isaac Chan, MD

Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)

Bispecific/Biparatopic Antibodies in Breast Cancer (Zanidatimab, PM8002, etc)

Paula Pohlmann, MD, PhD

Therapeutic and Preventive Vaccines for Triple Negative Breast Cancer

Therapeutic and Preventive Vaccines for Triple Negative Breast Cancer

Thomas Budd, MD

Innate immune Signaling in Breast Cancer

Innate immune Signaling in Breast Cancer

Andrei Goga, MD, PhD

Next Generation in Targeting DNA Repair

Next Generation in Targeting DNA Repair

Jennifer Litton, MD

ADCs: Other Novel Targets and Pathways

ADCs: Other Novel Targets and Pathways

Cynthia X. Ma, MD, PhD

Antibody Drug Conjugates (ADCS) to Enhance Anti-Tumor Immune Response

Antibody Drug Conjugates (ADCS) to Enhance Anti-Tumor Immune Response

Ana C. Garrido-Castro, MD

PI3K/AKT: Choices, Sequencing and New Agents

PI3K/AKT: Choices, Sequencing and New Agents

Neil Iyengar, MD

Novel Endocrine Therapies

Novel Endocrine Therapies

Irene Kang, MD

Who Needs Radiation Post Neoadjuvant Therapy

Who Needs Radiation Post Neoadjuvant Therapy

Nicolas Prionas, MD

Evaluating and Targeting Defects in DNA Repair

Evaluating and Targeting Defects in DNA Repair

Mark E. Robson, MD

Innovation in Tackling Triple Negative Residual Disease Following Preoperative KN-522 Regimen

Innovation in Tackling Triple Negative Residual Disease Following Preoperative KN-522 Regimen

Heather McArthur, MD

Strategies to Treat High Risk HR+, HER2 - Residual Disease (CDKi, IO, ADCs?)

Strategies to Treat High Risk HR+, HER2 - Residual Disease (CDKi, IO, ADCs?)

Lajos Pusztai, MD

Improving and Optimizing Adjuvant Treatment for HER2+ Residual Disease

Improving and Optimizing Adjuvant Treatment for HER2+ Residual Disease

Rita Nanda, MD

Neoadjuvant with Antibody Drug Conjugates (ADC)

Neoadjuvant with Antibody Drug Conjugates (ADC)

Rebecca Shatsky, MD

Neoadjuvant Immunotherapy for HR+ Disease

Neoadjuvant Immunotherapy for HR+ Disease

Laura Huppert, MD

Neoadjuvant Immunotherapy for Triple Negative Breast Cancer

Neoadjuvant Immunotherapy for Triple Negative Breast Cancer

Priyanka Sharma, MD

Neoadjuvant Endocrine Therapy

Neoadjuvant Endocrine Therapy

Jo Chien, MD

Understanding Mechanisms of ADC Resistance: Lessons Learned and New Directions

Understanding Mechanisms of ADC Resistance: Lessons Learned and New Directions

Leif Ellisen, MD, PhD

Multi-Cancer Early Detection (MCED)

Multi-Cancer Early Detection (MCED)

Luis Raez, MD

The Integrative Breast Cancer Subtypes: From Relapse Prediction to Novel Targets

The Integrative Breast Cancer Subtypes: From Relapse Prediction to Novel Targets

Christina Curtis, PhD

Use of Artificial Intelligence in Breast Cancer Diagnostics

Use of Artificial Intelligence in Breast Cancer Diagnostics

Anant Madabhushi, PhD

Exosomes in Diagnosis and Treatment

Exosomes in Diagnosis and Treatment

Mickensone Andre, PhD

Displaying 31 - 60 of 1,953

«
1
2
3
4
…
66
»

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok